Escolar Documentos
Profissional Documentos
Cultura Documentos
03562013 4479
REVISÃO REVIEW
melhorar a assistência e reduzir custos?
Abstract The scope of this study is to discuss data Resumo O objetivo deste estudo foi discutir da-
relating to the costs involved with Alzheimer’s dos relativos aos custos da Doença de Alzheimer
Disease and the initiatives in terms of care in or- (DA) e as iniciativas assistenciais para reduzir
der to reduce costs and help family members and custos e auxiliar a família e os cuidadores no ma-
caregivers to cope with the disease. The biggest nejo com a doença. O fator de maior custo para as
cost for people with mild Alzheimer’s Disease is pessoas com DA leve foi o do tempo do cuidador
the cost of time spent by the unremunerated care- não remunerado, enquanto que para aqueles com
giver, and for those at the advanced stages of the a doença em estágio avançado foi o dos cuidados
disease it is the cost of institutional care. In this relativos à institucionalização. Frente a esse pano-
respect, the literature proposes the adoption of rama a literatura propõe a adoção de modelos de
models of care that maximize the functional inde- atenção que maximizem a independência funcio-
pendence of the elderly and maintain their skills, nal do idoso e a manutenção de suas habilidades,
such as Day Care Centers for the Elderly and re- como a implantação do Centro Dia para Idosos e
habilitation programs and support offered to the de programas de reabilitação e amparo ao idoso
elderly and their family members. These models of e família. Esses modelos de atenção precisam ser
care need to be discussed, structured and deployed discutidos, estruturados e implantados na realida-
in the context of the Brazilian reality. de brasileira.
Key words Elderly, Cost, Alzheimer’s disease, De- Palavras-chave Idoso, Custo, Doença de Alzhei-
mentia mer, Demência
1
Escola de Artes, Ciências e
Humanidades, Universidade
de São Paulo. Av. Arlindo
Bétio 1000, Ermelino
Matarazzo. 03828-000
São Paulo SP Brasil.
biagutierrez@usp.br
2
Faculdade de Economia,
Administração e
Contabilidade, Universidade
de São Paulo.
4480
Gutierrez BAO et al.
Colaboradores Referências
BAO Gutierrez, HS Silva, C Guimarães e AC 1. World Health Organization (WHO). Dementia: a pu-
blic health priority. World Health Organization 2012.
Campino participaram igualmente de todas as
[acessado 2010 out 22]. Available from: http://whqlib-
etapas de elaboração do artigo. doc.who.int/publications/2012/9789241564458_eng.
pdf
2. Winblad B. Socio-economic perspectives of dementia
and costeffectiveness of treatment. 7th International
Geneva/Springfield. Symposium on Advances in Al-
zheimer Therapy, April 3-6, Geneva, Switzerland. 2002.
3. Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans
DA. Alzheimer disease in the USA population: pre-
valence estimates using the 2000 census. Arch Neurol
2003; 60(8):1119-1122.
4. Small GW, Donohue JA, Brooks RL. An economic
evaluation of donepezil in the treatment of Alzheimer’s
disease. Clin Ther 1998; 20(4):838-850.
5. Fratiglioni L, De Ronchi D, Aguero-Torres H. Worldwi-
de prevalence and incidence of dementia. Drugs Aging
1999; 15(5):365-375.
6. Hebert LE, Scherr PA, Beckett LA, Albert MS, Pilgrim
DM, Chown MJ, Funkenstein HH, Evans DA. Age-spe-
cific incidence of Alzheimer’s disease in a community
population. JAMA 1995; 273(17):1354-1359.
7. Burlá C, Camarano AA, Kanso S, Fernandes D, Nu-
nes R. Panorama prospectivo das demências no Bra-
sil: um enfoque demográfico. Cien Saude Colet 2013;
18(10):2949-2956
8. Wimo A, Winblada B, Linus JL. The worldwide societal
costs of dementia: estimates for 2009. Alzheimers De-
ment 2010; 6(2):98-103,
9. Bloom BS, Pouvourville N, Straus WL. Cost of illness
of Alzheimer’s Disease: How useful are current estima-
tes? Gerontologist 2003; 43(2):158-164.
10. Meek PD, McKeithan K, Schumock GT. Economic con-
siderations in Alzheimer’s disease. Pharmacotherapy
1998; 18(Pt. 2):68-73.
11. Brookmeyer R, Gray S, Kawas C. Projections of Alzhei-
mer’s disease in the United States and the public health
impact of delaying disease onset. Am J Public Health
1998; 88():1337-1342.
12. McCallion H. Dementia Training. Mental Health Prac-
tice 2009; 12(7):8.
13. Hux MJ, O’Brien BJ, Iskedjian M, et al. Relation betwe-
en severity of Alzheimer’s disease and costs of caring.
CMAJ 1998; 159(5):457-465.
4486
Gutierrez BAO et al.
14. Schneider J, Murray J, Banerjee S, Mann A. EUROCA- 27. Alzheimer’s Disease International. World Alzheimer Re-
RE: a cross-national study of co-resident spouse carers port. 2009. [acessado 2010 out 22]. Available at: http://
for people with Alzheimer’s disease: I-Factors associa- www.alz.co.uk/research/files/WorldAlzheimerReport
ted with carer burden. Int. J Geriatr Psychiatry 1999; -ExecutiveSummary.pdf
14(8):651-661. 28. Trojanowski JQ, Arnold SE, Karlawish JH, Brunden K,
15. Cuijpers P. Depressive disorders in caregivers of de- Cary M, Davatzikos C, Detre J, Gaulton G, Grossman
mentia patients: a systematic review. Aging Ment Health M, Hurtig H, Jedrziewski K, McCluskey L, Naylor M,
2005; 9(4):325-330. Polsky D, Schellenberg GD, Siderowf A, Shaw LM, Van
16. Lopes MA, Bottino CMC. Prevalência de demência em Deerlin V, Wang LS, Werner R, Xie SX, Lee VM. Design
diversas regiões do mundo: análise dos estudos epide- of comprehensive Alzheimer’s disease centers to ad-
miológicos de 1994 a 2000. Arq Neuropsiquiatr 2002; dress unmetnational needs. Alzheimers Dement 2010;
60(1):61-69. 6(2):150-155.
17. Nitrini R, Bottino CMC, Albala C, Custodio Capuñay 29. Franciulli, SE, Ricci NA, Lemos ND, Cordeiro RC,
NS, Ketzoian C, Llibre Rodriguez JJ, Maestre GE, Ra- Gazzola JM. A modalidade de assistência Centro-Dia
mos-Cerqueira AT, Caramelli P. Prevalence of dementia Geriátrico: efeitos funcionais em seis meses de acom-
in Latin America: a collaborative study of population panhamento multiprofissional. Cien Saude Colet 2007;
-based cohorts. Int Psychogeriatr 2009; 21(4):622-630. 12(2):373-380.
18. Scazufca M, Menezes PR, Vallada HP, Crepaldi AL, Pas- 30. Prigerson HG. Costs to society of family caregiving for
tor-Valero, Coutinho MS, Di RienzoV, Almeida P. High patients with end-stage Alzheimer’s disease. N Engl J
prevalence of dementia among older adults from poor Med 2003; 349(20):1891-1892.
socioeconomic backgrounds in São Paulo, Brazil. Int 31. Callahan CM, Boustani MA, Unverzagt FW, Austrom
Psychogeriatr 2008; 20(2):394-405. MG, Damush TM, Perkins AJ, Fultz BA, Hui SL, Cou-
19. Veras P, Caldas CP, Dantas SB, Sancho LG, Sicsú B, nsell SR, Hendrie HC. Effectiveness of collaborative
Motta LB. Demented elderly people living at home in care for older adults with Alzheimer disease in pri-
Rio de Janeiro, Brazil: Evaluation of expenditure care. mary care: a randomized controlled trial. JAMA 2006;
Psychogeriatrics 2008; 8(2):88-95. 295(18):2148-2157.
20. Karsch UM. Idosos dependentes: famílias e cuidadores. 32. Zarit SH. Empirically supported treatment for family
Cad Saude Publica 2003; 19(3):861-866. caregivers. In: Qualls SH, Zarit SH, editors. Aging fami-
21. Lebrão ML, Duarte YAO, organizadores. Sabe - Saúde, lies and caregiving. Hoboken, New Jersey: John Wiley &
bem-estar e envelhecimento – O projeto Sabe no municí- Sons Inc; 2009. p. 131-154.
pio de São Paulo: uma abordagem inicial. Brasília: Orga- 33. Wils G, Fink-Heitz M. Assisted vacations for men with
nização Pan-Americana da Saúde (OPAS); 2003. dementia and their caregiving spouses: evaluation of
22. Giacomin KC, Peixoto SV, Uchoa E, Lima-Costa MF. health-related effects. Gerontol 2008; 48(1):115-120.
Estudo de base populacional dos fatores associados à 34. Eloniemi-Sulkava U, Saarenheimo M, Laakkonenm
incapacidade funcional entre idosos na Região Metro- M-L, Pietilä M, Savikko N, Kautiainen H, Tilvis RS,
politana de Belo Horizonte, Minas Gerais, Brasil. Cad Pitkälä KH. Family care as collaboration: effectiveness
Saude Publica 2008; 24(6):1260-1270. of a multicomponent support program for elderly cou-
23. Lima-Costa MF, Barreto SM, Giatti L. Condições de ples with dementia. Randomized controlled interven-
saúde, capacidade funcional, uso de serviços de saúde e tion study. JAGS 2009; 57(12):2200-2208.
gastos com medicamentos da população idosa brasilei- 35. Caldas CP, Veras RP, Motta LB, Lima KC, Kisse CBS,
ra: um estudo descritivo baseado na Pesquisa Nacional Trocado CVM, Guerra ACLC. Rastreamento do risco
por Amostra de Domicílios. Cad Saude Publica 2003; de perda funcional: uma estratégia fundamental para a
19(3):735-743. organização da Rede de Atenção ao Idoso. Cien Saude
24. Alzheimer’s Society. Financial cost of dementia. [aces- Colet 2013; 18(12):3495-506
sado 2010 fev 28]. Available at: http://www.alzheimers. 36. The Alzheimer’s Study Group Report. A National Al-
org.uk/site/scripts/documents_info.php?document zheimer’s Strategic Plan. The Report of the Alzheimer’s
ID=418 Study Group. 2008. [acessado 2010 nov 30]. Available
25. Zhu C, Leibman C, McLaughlin T, Zbrozek AS, Scar- at: www.alz.org/news_and_events_16243.asp
meas N, Albert M, Brandt J, Blacker D, Sano M, Stern Y.
Patient dependence and longitudinal changes in costs
of care in Alzheimer’s Disease. Dement Geriatr Cogn
Disord 2008; 26(5):416-423.
26. Wolfs CAG, Dirksen CD, Kessels A, Severens JL, Verhey
FR. Economic evaluation of an integrated diagnostic Artigo apresentado em 15/03/2013
approach for psychogeriatric patients. Arch Gen Psy- Aprovado em 05/04/2013
chiatry 2009; 66(3):313-323. Versão final apresentada em 07/04/2013